Publicação

Acetylation genotype and the genetic susceptibility to postate cancer in a Southern European population

Ver documento

Detalhes bibliográficos
Resumo:Epidemiologic studies have suggested that environmental factors and diet are important risk factors in the pathogenesis of prostate cancer. The N-acetyltransferases (NAT) are important enzymes in activation and inactivation of various carcinogens, including those found in well-cooked meat and cigarette smoke. METHODS. We analyzed DNA samples from 146 prostate cancer patients and 174 healthy men. We used PCR–RFLP method to analyze NAT1 and NAT2 polymorphisms. RESULTS. We did not find statistically significant differences in NAT1 genotypes frequencies between prostate cancer patients and control group. We observed an association of the slow acetylator genotype, NAT2*6/NAT2*6 with prostate cancer protection (P¼0.017;OR¼0.31, 95% CI 0.11–0.84). Multivariate logistic regression analysis confirmed this association (0.030; OR¼0.32, 95% CI 0.12–0.89). CONCLUSIONS. Our results indicate a role of NAT2 polymorphisms in the carcinogenic pathway of prostate cancer, specifically in a population of Southern Europe.
Autores principais:Costa, Sandra Maria Araújo da
Outros Autores:Pinto, Daniela; Morais, António; Vasconcelos, André; Oliveira, Jorge; Lopes, Carlos; Medeiros, Rui
Assunto:NAT Polymorphisms Prostate cancer Heterocyclic aromatic Acetylation heterocyclic aromatic amines
Ano:2005
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso aberto
Instituição associada:Universidade do Minho
Idioma:inglês
Origem:RepositóriUM - Universidade do Minho
Descrição
Resumo:Epidemiologic studies have suggested that environmental factors and diet are important risk factors in the pathogenesis of prostate cancer. The N-acetyltransferases (NAT) are important enzymes in activation and inactivation of various carcinogens, including those found in well-cooked meat and cigarette smoke. METHODS. We analyzed DNA samples from 146 prostate cancer patients and 174 healthy men. We used PCR–RFLP method to analyze NAT1 and NAT2 polymorphisms. RESULTS. We did not find statistically significant differences in NAT1 genotypes frequencies between prostate cancer patients and control group. We observed an association of the slow acetylator genotype, NAT2*6/NAT2*6 with prostate cancer protection (P¼0.017;OR¼0.31, 95% CI 0.11–0.84). Multivariate logistic regression analysis confirmed this association (0.030; OR¼0.32, 95% CI 0.12–0.89). CONCLUSIONS. Our results indicate a role of NAT2 polymorphisms in the carcinogenic pathway of prostate cancer, specifically in a population of Southern Europe.